Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients

doi:10.4254/wjh.v8.i35.1569

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9437)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

405

WORD

354

HTML

2933

Figures (1-2)

228

Tables (1-3)

241

Sum=4161

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

621

Download

1227

Sum=1848

Publishing Process of This Article

Item

Count

Browse

1355

Download

2073

Sum=3428

Dec 18, 2016 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Hepatol. Dec 18, 2016; 8(35): 1569-1575
Published online Dec 18, 2016. doi: 10.4254/wjh.v8.i35.1569

Full Size Figure Download Figure

Figure 2 Pretransplant survival based on very low QuantiFERON. A: Infection free survival by Child-Pugh; B: Infection free survival by MELD; C: Infection free survival by QFM; D: Infection and mortality free survival by QFM; E: Pretransplant survival based on very low QFM. QFM: QuantiFERON-Monitor; MELD: Model for end stage liver disease.

Citation: Sood S, Yu L, Visvanathan K, Angus PW, Gow PJ, Testro AG. Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World J Hepatol 2016; 8(35): 1569-1575
URL: https://www.wjgnet.com/1948-5182/full/v8/i35/1569.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i35.1569